Sunday, December 16, 2018 11:10:43 PM
CUIN2, you wrote <<Underwriter will have the offering “sold” before it opens at its new price on the market. >>
Then you gave quotes from the S1 that I guess you are thinking support what you wrote above.
I have found a S1 for iBIO back in June 2018 that also used Alliance Global. The wording in the underwriter section is similar to that NFUSZ. They priced it at .90 a share, just slightly BELOW MARKET (this was already a NYSE stock). No sign of an valuation independent of the market price in effect.
I don't see that what you have posted says anything significant to support your claim of a price higher than market. Perhaps you can explain further?
I see you just posted a link 'explaining' why this will be an IPO, but you twice ignored my question to you as to why the amended S1 had the words 'initial public offering' changed to 'public offering'? Clearly that didn't just happen by accident, so why did they do that CUIN2 if this is to be an IPO?
To claim this is an IPO against all evidence and to support this with a link that doesn't really support it - while having presumably a fair number of investors taking your word seriously - well, it needs to be treated responsibly, and calls out for more than a meager claim that you think it is possible.
If you want, here is the S1 for iBio, and press release about it:
https://www.otcmarkets.com/filing/html?id=12823728&guid=OynbUn2YNiKcYyh#TV496836_S1A_HTM_A_017
https://www.cnbc.com/2018/06/22/globe-newswire-ibio-inc-prices-16000000-public-offering.html
Then you gave quotes from the S1 that I guess you are thinking support what you wrote above.
I have found a S1 for iBIO back in June 2018 that also used Alliance Global. The wording in the underwriter section is similar to that NFUSZ. They priced it at .90 a share, just slightly BELOW MARKET (this was already a NYSE stock). No sign of an valuation independent of the market price in effect.
I don't see that what you have posted says anything significant to support your claim of a price higher than market. Perhaps you can explain further?
I see you just posted a link 'explaining' why this will be an IPO, but you twice ignored my question to you as to why the amended S1 had the words 'initial public offering' changed to 'public offering'? Clearly that didn't just happen by accident, so why did they do that CUIN2 if this is to be an IPO?
To claim this is an IPO against all evidence and to support this with a link that doesn't really support it - while having presumably a fair number of investors taking your word seriously - well, it needs to be treated responsibly, and calls out for more than a meager claim that you think it is possible.
If you want, here is the S1 for iBio, and press release about it:
https://www.otcmarkets.com/filing/html?id=12823728&guid=OynbUn2YNiKcYyh#TV496836_S1A_HTM_A_017
https://www.cnbc.com/2018/06/22/globe-newswire-ibio-inc-prices-16000000-public-offering.html
My philosophy is to just be honest and balanced, and let the market decide if it agrees or not.
Recent TONX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 08:10:34 PM
- TON Strategy Company Appoints Kevin Wilson as Chief Executive Officer • GlobeNewswire Inc. • 04/16/2026 08:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/11/2026 12:00:08 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/02/2026 08:15:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 03:35:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 12:50:34 PM
- TON Strategy Company Reports Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/31/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 01:30:14 PM
- TON Strategy Company Sets Fourth Quarter and Full Year 2025 Conference Call for Tuesday, March 31, 2026 at 9:00 a.m. ET • GlobeNewswire Inc. • 03/17/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:30:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 09:15:54 PM
- TON Strategy Company Announces Leadership Transition and Other Updates • GlobeNewswire Inc. • 01/28/2026 09:05:00 PM
- TON Strategy Company Announces Senior Officer Appointments • GlobeNewswire Inc. • 01/08/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 02:30:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2025 02:30:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 02:30:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2025 02:30:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2025 07:59:31 PM
- TON Strategy Company Welcomes Coinbase’s Launch of $TON Trading Across Global Platforms • Business Wire • 11/18/2025 11:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:10:38 PM
